(Q46708843)

English

Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues. The Casodex Combination Study Group

scientific article published in September 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10420149

Exploratory analysis on the effect of race on clinical outcome in patients with advanced prostate cancer receiving bicalutamide or flutamide, each in combination with LHRH analogues. The Casodex Combination Study Group (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10420149

1 reference

based on heuristic

inferred from title

author name string

McLeod DG

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10420149

Schellhammer PF

2

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10420149

Vogelzang NJ

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10420149

Soloway MS

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10420149

Sharifi R

5

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10420149

Block NL

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10420149

Venner PM

7

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10420149

Patterson AL

8

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10420149

Sarosdy MF

9

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10420149

Kelley RP

10

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10420149

Kolvenbag GJ

11

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10420149

publication date

1 September 1999

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10420149

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10420149

40

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10420149

4

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10420149

218-224

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10420149

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990901%2940%3A4%3C218%3A%3AAID-PROS2%3E3.0.CO%3B2-6

21 January 2018

Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990901%2940%3A4%3C218%3A%3AAID-PROS2%3E3.0.CO%3B2-6

21 January 2018

The National Cancer Data Base report on prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990901%2940%3A4%3C218%3A%3AAID-PROS2%3E3.0.CO%3B2-6

21 January 2018

Cancer statistics, 1994.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990901%2940%3A4%3C218%3A%3AAID-PROS2%3E3.0.CO%3B2-6

21 January 2018

Prostate-specific antigen as predictor of prostate cancer in black men and white men.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990901%2940%3A4%3C218%3A%3AAID-PROS2%3E3.0.CO%3B2-6

21 January 2018

Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990901%2940%3A4%3C218%3A%3AAID-PROS2%3E3.0.CO%3B2-6

21 January 2018

Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990901%2940%3A4%3C218%3A%3AAID-PROS2%3E3.0.CO%3B2-6

21 January 2018

Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: final report of a double-blind, randomized, multicenter trial. Casodex Combination Study Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990901%2940%3A4%3C218%3A%3AAID-PROS2%3E3.0.CO%3B2-6

21 January 2018

A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer. Casodex Combination Study Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990901%2940%3A4%3C218%3A%3AAID-PROS2%3E3.0.CO%3B2-6

21 January 2018

Maximal androgen blockade for patients with metastatic prostate cancer: outcome of a controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy. Casodex Combination Study Group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990901%2940%3A4%3C218%3A%3AAID-PROS2%3E3.0.CO%3B2-6

21 January 2018

Prostate cancer: trends in mortality and stage-specific incidence rates by racial/ethnic group in Los Angeles County, California (United States).

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990901%2940%3A4%3C218%3A%3AAID-PROS2%3E3.0.CO%3B2-6

21 January 2018

Removal of the financial barrier to health care: does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veterans Affairs system

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990901%2940%3A4%3C218%3A%3AAID-PROS2%3E3.0.CO%3B2-6

21 January 2018

Black-white differences in the stage at presentation of prostate cancer in the district of columbia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990901%2940%3A4%3C218%3A%3AAID-PROS2%3E3.0.CO%3B2-6

21 January 2018

Prostate cancer, race, and socioeconomic status: inadequate adjustment for social factors in assessing racial differences

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819990901%2940%3A4%3C218%3A%3AAID-PROS2%3E3.0.CO%3B2-6

21 January 2018

Identifiers

10.1002/(SICI)1097-0045(19990901)40:4<218::AID-PROS2>3.0.CO;2-6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10420149

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/10420149

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46708843&oldid=2127678794"